Topics Panel Section
The events of 2020 and their aftermath have made it clear that ESG is not a fad that will recede, even during a crisis. If anything, 2020 made ESG's importance clear and firmly established ESG as being a more important engagement and voting topic going forward.
U.S.-listed Chinese companies are finding that a secondary listing in Hong Kong is not just a hedge against U.S. regulatory uncertainty but also a good way to raise more capital. Meanwhile, Hong Kong is making it easier for Chinese biotech companies to list there.
Under the Biden administration, corporations can expect the DOJ and congressional investigations to place greater focus on the private sector. Democrats in the 117th Congress likely will focus on issues including the response to the COVID-19 pandemic, environmental concerns, drug pricing and antitrust questions surrounding Big Tech.
As the U.S. changes administration, there is significant interest in how the country’s relationship with China may evolve with respect to trade, national security and government enforcement. Although some modifications in tone and approach under the Biden administration are possible, fundamental changes in these areas appear unlikely.
10th Annual Forum on US Export and Reexport Compliance for Canadian OperationsJanuary 26-27, 2021
The State of Securities Class Actions: 2020 Trends and a Look AheadJanuary 27, 2021
The Eye of the Storm: A Look at Current Trends and Distressed Opportunities for 2021January 27, 2021
Recent Developments in Distressed Debt, Restructurings and Workouts 2021January 28, 2021